Columbia Care Inc. CCHW CCHW CCHWF 3LP released Monday preliminary results for the full year ended December 31, 2021, reporting revenue of $460 million, up by 156% from 2020.
At this time, the company is working to complete its first U.S. GAAP audit and will report its financial results for the fourth quarter and full-year ended December 31, 2021, before U.S. financial markets open on Thursday, March 24, 2022.
Full Year Preliminary Results Summary
- Revenue amounted to $460.08 million, compared to $179.50 million in 2020;
- Gross profit was $194.02 million, versus $62.14 million in the previous year;
- Net loss was $146.85 million, compared to a net loss of $119.65 million in 2020;
- Adjusted EBITDA was a gain of $57.85 million, versus adjusted EBITDA loss of $19.8 million in the prior year;
Columbia Care’s chief growth officer, Jesse Channon, will be one of the speakers at the Benzinga Cannabis Capital Conference in Miami. There’s still time to sign up for the event that will host many top names in the cannabis industry. Click here for more info.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!